HPGC Renmintongtai Pharmaceutical Corporation (SHA:600829)

China flag China · Delayed Price · Currency is CNY
10.49
+0.11 (1.06%)
Mar 10, 2026, 3:00 PM CST
37.12%
Market Cap 6.08B
Revenue (ttm) 10.22B
Net Income (ttm) 119.14M
Shares Out 579.89M
EPS (ttm) 0.21
PE Ratio 51.05
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 5,055,147
Average Volume 9,807,866
Open 10.50
Previous Close 10.38
Day's Range 10.38 - 10.51
52-Week Range 6.40 - 18.13
Beta 0.25
RSI 41.70
Earnings Date Apr 11, 2026

About SHA:600829

HPGC Renmintongtai Pharmaceutical Corporation engages in the wholesale and retail of pharmaceutical products in China and internationally. The company offers Chinese and Western patent medicines, Chinese herbal medicines and slices, chemical preparations, antibiotics, biological products, biochemical drugs, medical devices, and health products, as well as tonic health, daily necessities, and cosmetics products. It also provides logistics services, including warehousing and distribution services; and hospital services comprising medical treatmen... [Read more]

Sector Healthcare
Founded 1950
Employees 2,870
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600829
Full Company Profile

Financial Performance

In 2024, SHA:600829's revenue was 10.05 billion, a decrease of -3.29% compared to the previous year's 10.39 billion. Earnings were 213.27 million, a decrease of -27.00%.

Financial Statements

News

There is no news available yet.